NEW YORK (GenomeWeb) – Japanese genetic research and testing firm Genesis Healthcare announced today that it has completed the sale of ¥1.5 billion ($13.8 million) of newly issued shares to Rakuten.
In connection with the transaction, Rakuten Chairman and CEO Hiroshi Mikitani will join Genesis' board as an external director.